Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MAF |
| Upstream (Parents) |
|---|
| (<<) TFAP2A → MAF |
| (<<) IKZF1 → MAF |
| (<<) IRF1 → MAF |
| (<<) FLI1 → MAF |
| (<<) IRF8 → MAF |
| (<<) GLIS2 → MAF |
| (<<) HCLS1 → MAF |
| (<<) TCF12 → MAF |
| (<<) HHEX → MAF |
| (<<) EPAS1 → MAF |
| (<<) MEF2C → MAF |
| (<<) LEF1 → MAF |
| (<<) CREBL2 → MAF |
| (<<) VAV1 → MAF |
| (<<) FOXO1 → MAF |
| Downstream (Children) |
|---|
| MAF → ENO1 (>>) |
| MAF → WT1 (>>) |
| MAF → HOPX (>>) |
| MAF → XBP1 (>>) |
| MAF → IRF6 (>>) |
| MAF → HES1 (>>) |
| MAF → ETV5 (>>) |
| MAF → TGIF1 (>>) |
| MAF → AFF4 (>>) |
| MAF → HMGB1 (>>) |
| MAF → STAT3 (>>) |
| MAF → GTF2H4 (>>) |
| MAF → PHF5A (>>) |
| MAF → SUPT4H1 (>>) |
| MAF → GCFC1 (>>) |
| MAF → EDF1 (>>) |
| MAF → CBFA2T3 (>>) |
| MAF → C1orf85 (>>) |
| MAF → ARNT (>>) |
